1. Home
  2. LRHC vs AZTR Comparison

LRHC vs AZTR Comparison

Compare LRHC & AZTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo La Rosa Holdings Corp.

LRHC

La Rosa Holdings Corp.

HOLD

Current Price

$0.58

Market Cap

1.6M

Sector

N/A

ML Signal

HOLD

Logo Azitra Inc

AZTR

Azitra Inc

HOLD

Current Price

$0.24

Market Cap

1.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LRHC
AZTR
Founded
2004
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6M
1.9M
IPO Year
2022
2023

Fundamental Metrics

Financial Performance
Metric
LRHC
AZTR
Price
$0.58
$0.24
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
791.9K
20.8M
Earning Date
04-17-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
26.17
5.06
EPS
N/A
N/A
Revenue
$69,448,786.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
118.67
N/A
52 Week Low
$0.08
$0.10
52 Week High
$11.21
$1.40

Technical Indicators

Market Signals
Indicator
LRHC
AZTR
Relative Strength Index (RSI) 37.16 56.69
Support Level $0.36 $0.14
Resistance Level $0.75 $0.25
Average True Range (ATR) 0.09 0.04
MACD 0.01 0.01
Stochastic Oscillator 11.16 51.45

Price Performance

Historical Comparison
LRHC
AZTR

About LRHC La Rosa Holdings Corp.

La Rosa Holdings Corp operates in the U.S. residential real estate market. It is a holding company for agent-centric, technology-integrated, cloud-based, multi-service real estate companies. The company's business is organized based on the services it provides internally to the agents and to the public, which are residential and commercial real estate brokerage, franchising, real estate brokerage education and coaching, and property management. The company has six reportable segments, namely: Real Estate Brokerage Services (Residential), Franchising Services, Coaching Services, Property Management, Real Estate Brokerage Services (Commercial), and Title Settlement and Insurance. It derives maximum revenue from the Real Estate Brokerage Services (Residential) segment.

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.

Share on Social Networks: